Overview

Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis

Status:
Completed

Trial end date:
2008-11-01

Target enrollment:

Participant gender:

Summary

OBJECTIVES: I. Determine the effects of alendronate sodium on skeletal remodeling and bone mineral density of the hip and spine in children with high-turnover idiopathic juvenile osteoporosis.

Phase:

Phase 2

Details

Lead Sponsor:

Medical University of South Carolina

Collaborator:

Merck Sharp & Dohme Corp.

Treatments:

Alendronate